Cellular Mechanism for Mibefradil-Induced Vasodilation of Renal Microcirculation: Studies in the Isolated Perfused Hydronephrotic Kidney
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2003 |
|---|---|
| Erschienen: |
2003 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of cardiovascular pharmacology - 42(2003), 6, Seite 697-702 |
| Beteiligte Personen: |
Hayashi, Koichi [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1653945532 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1653945532 | ||
| 003 | DE-627 | ||
| 005 | 20230513062210.0 | ||
| 007 | tu | ||
| 008 | 031126s2003 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw031126 |
| 035 | |a (DE-627)OLC1653945532 | ||
| 035 | |a (DE-599)GBVOLC1653945532 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Hayashi, Koichi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cellular Mechanism for Mibefradil-Induced Vasodilation of Renal Microcirculation: Studies in the Isolated Perfused Hydronephrotic Kidney |
| 264 | 1 | |c 2003 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Ozawa, Yuri |4 oth | |
| 700 | 1 | |a Wakino, Shu |4 oth | |
| 700 | 1 | |a Kanda, Takeshi |4 oth | |
| 700 | 1 | |a Homma, Koichiro |4 oth | |
| 700 | 1 | |a Takamatsu, Ichiro |4 oth | |
| 700 | 1 | |a Tatematsu, Satoru |4 oth | |
| 700 | 1 | |a Saruta, Takao |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular pharmacology |d Hagerstown, Md. : Wolters Kluwer Lippincott Williams & Wilkins, 1979 |g 42(2003), 6, Seite 697-702 |w (DE-627)129941298 |w (DE-600)391970-5 |w (DE-576)015504743 |x 0160-2446 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2003 |g number:6 |g pages:697-702 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_2002 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2012 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4314 | ||
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 42 |j 2003 |e 6 |h 697-702 |g 6 | ||